Physician profile
Michael S Rhee
NPI 1124255021
$24,353.10
in general payments reported to CMS, 2019-2025
9 companies · $97.24 in 2025
The $97.24 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,646 · 2020: $14K · 2021: $46.79 · 2022: $74.87 · 2023: $150 · 2024: $116 · 2025: $97.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $23,856.86 | 2019-2020 | |
| Stryker Corporation | $134.64 | 2023 | Everest Spinal System |
| Boston Scientific Corporation | $98.13 | 2019-2023 | |
| Alphatec Spine, INC | $88.14 | 2024 | Invictus Mis, Invictus Open |
| Medtronic, INC. | $56.75 | 2021-2025 | Mazor X System |
| Amgen INC. | $34.16 | 2025 | Evenity |
| Globus Medical, INC. | $29.45 | 2025 | Sable |
| Integra Lifesciences Corporation | $28.03 | 2024 | Codman Hakim, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Aesculap, INC. | $26.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.